Press Releases

View Archive: 2013  |  2012  |  2011  |  2010  |  2009  |  2008  |  2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000  |  1999  |  1998

June 18, 2013
Cytokinetics Announces Results From ATOMIC-AHF Will Be Presented At Late Breaking Clinical Trials Session At The European Society Of Cardiology Congress 2013

June 17, 2013
Cytokinetics Set to Join Russell Global Index

June 12, 2013
Amgen and Cytokinetics Announce Expansion of License for Omecamtiv Mecarbil

June 4, 2013
Cytokinetics Announces Publications Relating to Fast Skeletal Troponin Activation in Nemaline Myopathy

May 15, 2013
Cytokinetics to Hold Annual Meeting of Stockholders

April 30, 2013
Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results

April 16, 2013
Cytokinetics to Announce First Quarter Results on April 30, 2013

April 4, 2013
Cytokinetics Announces Grant From Families with Spinal Muscular Atrophy for Preclinical Development of Tirasemtiv

April 1, 2013
Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107

March 29, 2013
Cytokinetics to Present at Upcoming Healthcare Conferences

March 21, 2013
Cytokinetics Announces Presentation of Phase IIA Clinical Trial Data of Tirasemtiv in Patients with Myasthenia Gravis

March 18, 2013
Cytokinetics Announces Update to Heart Failure Program

March 13, 2013
Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis

March 11, 2013
Cytokinetics to Present at 25th Annual Roth Conference

February 22, 2013
Cytokinetics to Present at Upcoming Healthcare Conferences

February 12, 2013
Cytokinetics Announces Opening of COSMIC-HF, A Phase II Clinical Trial of Oral Formulations of Omecamtiv Mecarbil in Patients with Heart Failure

February 8, 2013
Cytokinetics to Present at BIO CEO and Investor Conference

February 8, 2013
Cytokinetics Announces Changes to Its Board of Directors

February 5, 2013
Cytokinetics, Incorporated Reports Fourth Quarter 2012 Financial Results

January 29, 2013
Cytokinetics to Announce Fourth Quarter Results on February 5, 2013

January 25, 2013
Cytokinetics, Incorporated Receives NASDAQ Notice of Minimum Bid Price Compliance